Related Experiment Video
Updated: Jun 15, 2026
11:05
Behavioral Characterization of an Angelman Syndrome Mouse Model
Published on: October 20, 2023
Preview. Angelman syndrome: finding the lost arc.
Hwan-Ching Tai1, Erin M Schuman
1Division of Biology, Caltech, Pasadena, CA 91125, USA.
Cell
|March 10, 2010
Summary
Angelman syndrome, a neurodevelopmental disorder, is linked to UBE3A gene mutations. Researchers identified Arc as a UBE3A substrate, revealing its role in synaptic defects and cognitive deficits.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Angelman syndrome is a rare neurodevelopmental disorder.
- It results from mutations in the maternally inherited UBE3A gene.
- UBE3A encodes a ubiquitin ligase enzyme.
Discussion:
- Greer et al. (2010) identified Arc as a substrate of the UBE3A protein.
- Arc plays a crucial role in the endocytosis of neuronal AMPA receptors.
- This finding provides insight into the synaptic dysfunction observed in Angelman syndrome.
Key Insights:
- Identification of Arc as a UBE3A substrate.
- Demonstration of Arc's role in AMPA receptor trafficking.
- Linking synaptic defects to cognitive impairments in Angelman syndrome.
Outlook:
- Further research into the UBE3A-Arc pathway may reveal therapeutic targets.
- Understanding Arc's function could lead to novel treatments for Angelman syndrome.
- This study opens new avenues for investigating neurodevelopmental disorders.
